Molecular epidemiology of metallo-β-lactamase-producing pseudomonas aeruginosa in the Calgary Health Region: Emergence of VIM-2-producing isolates

Journal of Clinical Microbiology

Volumn 45, Issue 2, 2007, Pages 294-298

  Pitout, Johann D D ^a,c   Chow, Barbara L ^a   Gregson, Daniel B ^a,b   Laupland, Kevin B ^a,b   Elsayed, Sameer ^a   Church, Deirdre L ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c CALGARY LABORATORY SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; ISOENZYME; METALLO BETA LACTAMASE; PROTEIN IMP 7; PROTEIN SPEI; PROTEIN VIM 2; RESTRICTION ENDONUCLEASE; UNCLASSIFIED DRUG;

AACA4 GENE; AACC1 GENE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BONE MARROW TRANSPLANTATION; CANADA; CONTROLLED STUDY; EMERGENCY CARE; GENE CASSETTE; GENETIC ANALYSIS; GENETIC VARIABILITY; HEALTH CARE; HOSPITAL INFECTION; HOSPITAL LABORATORY; INTEGRON; INTENSIVE CARE UNIT; MOLECULAR EPIDEMIOLOGY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; SEQUENCE ANALYSIS; STENOTROPHOMAS MALTOPHILIA; STREPTOCOCCUS PNEUMONIAE;

ALBERTA; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS PNEUMONIAE;

EID: 33847069980     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01694-06     Document Type: Article

References (25)

1. Church, D. L., C. Don-Joe, and B. Unger. 2000. Effects of restructuring on the performance of microbiology laboratories in Alberta. Arch. Pathol. Lab. Med. 124:357-361.
2. Denton, M., N. J. Todd, K. G. Kerr, P. M. Hawkey, and J. M. Littlewood. 1998. Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples. J. Clin. Microbiol. 36:1953-1958.
3. Deplano, A., O. Denis, L. Poirel, D. Hocquet, C. Nonhoff, B. Byl, P. Nordmann, J. L. Vincent, and M. J. Struelens. 2005. Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa. J. Clin. Microbiol. 43:1198-1204.
4. Fiett, J., A. Baraniak, A. Mrowka, M. Fleischer, Z. Drulis-Kawa, L. Naumiuk, A. Samet. W. Hryniewicz, and M. Gniadkowski. 2006. Molecular epidemiology of acquired-metallo-β-lactamase-producing bacteria in Poland. Antimicrob. Agents Chemother. 50:880-886.
5. Giakkoupi, P., G. Petrikkos, L. S. Tzouvelekis, S. Tsonas, N. J. Legakis, and A. C. Vatopoulos. 2003. Spread of integron-associated VIM-type metallo-β-lactamase genes among imipenem-nonsusceptible Pseudomonas aeruginosa strains in Greek hospitals. J. Clin. Microbiol. 41:822-825.
6. IMP-7. Antimicrob. Agents Chemother. 46:255-258.
7. Hunter, S. B., P. Vauterin, M. A. Lambert-Fair, M. S. Van Duyne, K. Kubota, L. Graves, D. Wrigley, T. Barrett, and E. Ribot. 2005. Establishment of a universal size standard strain for use with the PulseNet standardized pulsed-field gel electrophoresis protocols: converting the national databases to the new size standard. J. Clin. Microbiol. 43:1045-1050.
8. Kimura, S., J. Alba, K. Shiroto, R. Sano, Y. Niki, S. Maesaki, K. Akizawa, M. Kaku, Y. Watanuki, Y. Ishii, and K. Yamaguchi. 2005. Clonal diversity of metallo-β-lactamase-possessing Pseudomonas aeruginosa in geographically diverse regions of Japan. J. Clin. Microbiol. 43:458-461.
9. Laupland, K. B., M. D. Parkins, D. L. Church, D. B. Gregson, T. J. Louie, J. M. Conly, S. Elsayed, and J. D. Pitout. 2005. Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region: importance of metallo-β-lactamase (MBL)-producing strains. J. Infect. Dis. 192:1606-1612.
10. SIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob. Agents Chemother. 49:4485-4491.
11. Louie, M., L. Louie, G. Papia, J. Talbot, M. Lovgren, and A. E. Simor. 1999. Molecular analysis of the genetic variation among penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae serotypes in Canada. J. Infect. Dis. 179:892-900.
12. National Committee for Clinical Laboratory Standards. 2004. Performance standards for antimicrobial susceptibility testing; 14th informational supplement M100-S14. National Committee for Clinical Laboratory Standards, Wayne, PA.
13. Paterson, D. L. 2006. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin. Infect. Dis. 43(Suppl. 2):S43-S48.
14. Pitout, J. D., D. B. Gregson, L. Poirel, J. A. McClure, P. Le, and D. L. Church. 2005. Detection of Pseudomonas aeruginosa producing metallo-β-lactamases in a large centralized laboratory. J. Clin. Microbiol. 43:3129-3135.
15. Poirel, L., T. Naas, D. Nicolas, L. Collet, S. Bellais, J. D. Cavallo, and P. Nordmann. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase, and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44:891-897.
16. Quinteira, S., J. C. Sousa, and L. Peixe. 2005. Characterization of In100, a new integron carrying a metallo-β-lactamase and a carbenicillinase, from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49:451-453.
17. Riccio, M. L., L. Pallecchi, J. D. Docquier, S. Cresti, M. R. Catania, L. Pagani, C. Lagatolla, G. Cornaglia, R. Fontana, and G. M. Rossolini. 2005. Clonal relatedness and conserved integron structures in epidemiologically unrelated Pseudomonas aeruginosa strains producing the VIM-1 metallo-β-lactamase from different Italian hospitals. Antimicrob. Agents Chemother. 49:104-110.
18. Romao, C. M., Y. N. Faria, L. R. Pereira, and M. D. Asensi. 2005. Susceptibility of clinical isolates of multiresistant Pseudomonas aeruginosa to a hospital disinfectant and molecular typing. Mem. Inst. Oswaldo Cruz 100: 541-548.
19. Rossolini, G. M. 2005. Acquired metallo-β-lactamases: an increasing clinical threat. Clin. Infect. Dis. 41:1557-1558.
20. Speijer, H., P. H. Savelkoul, M. J. Bonten, E. E. Stobberingh, and J. H. Tjhie. 1999. Application of different genotyping methods for Pseudomonas aeruginosa in a setting of endemicity in an intensive care unit. J. Clin. Microbiol. 37:3654-3661.
21. Spencker, F. B., S. Haupt, M. C. Claros, S. Walter, T. Lietz, R. Schille, and A. C. Rodloff. 2000. Epidemiologic characterization of Pseudomonas aeruginosa in patients with cystic fibrosis. Clin. Microbiol. Infect. 6:600-607.
22. Talbot, G. H., J. Bradley, J. E. Edwards, Jr., D. Gilbert, M. Scheld, and J. G. Bartlett. 2006. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin. Infect. Dis. 42:657-668.
23. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
24. Toleman, M. A., D. Biedenbach, D. M. Bennett, R. N. Jones, and T. R. Walsh. 2005. Italian metallo-β-lactamases: a national problem? Report from the SENTRY Antimicrobial Surveillance Programme. J. Antimicrob. Chemother. 55:61-70.
25. Walsh, T. R., M. A. Toleman, L. Poirel, and P. Nordmann. 2005. Metallo-β-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18:306-325.